Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVEFENACIN vs REVLIMID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVEFENACIN vs REVLIMID: Safety Overview

Metric REVEFENACIN REVLIMID
Total FAERS Reports 280 8,878
Deaths Reported 11 1,233
Death Rate 3.9% 13.9%
Hospitalizations 23 3,659
Average Patient Age 72.4 yrs 69.5 yrs
% Female Patients 59.1% N/A
FDA Approval Date Nov 9, 2018 N/A
Manufacturer Viatris Specialty LLC N/A
Route RESPIRATORY (INHALATION) N/A
Marketing Status Prescription N/A